Nov.2019 Signing ceremony for strategic cooperation between Hong Kong Winhealth Pharma Group and China Resources Guangdong Pharmaceutical Co., Ltd. 

In November 2019,Zhejiang Medical Technology Development Co., Ltd. put on 'List of key to-be-listed enterprises in Hangzhou City' 

November 1 to 3，2019 Strategic cooperation was achieved with Chinese Pharmacists Association，Winhealth Pharma Group expands new cooperation in rare disease field.

 October 31, 2019. Hong Kong Winhealth Pharma Group and Daiichi-Sankyo come to a strategic cooperation agreement on Asmeton®

September 30, 2019  Winhealth Pharma Group (Hong Kong) announced the formal establishment of a long-term strategic partnership with JD.com's self-operated pharmacy. 

From September 11 to 12, 2019, the 14th China Pharmaceutical and Medtech Business Development Summit Forum, which was co-hosted by Winhealth Pharma Group, was successfully held in Yantai, Shandong province. Winhealth Pharma Group won the 'BD Influence Award'! 

From September 6 to 9, 2019, the 'Honor and Brilliance Celebration and Sales of 3 Million Boxes of Coniel®', which was organized by Winhealth Pharma Group and Kyowa Hakko Kirin, was held in Kyoto and Osaka, Japan.

September 5, 2019 The strategic cooperation agreement on Flumarin was reached with Shionogi Pharmaceutical Co., Ltd. 

April 26, 2019 A strategic cooperation agreement was signed with Cumberland Pharmaceuticals, and an exclusive commercial license agreement for Ibuprofen Injection and other products in the Chinese market was also signed. 

April 28, 2019  An exclusive cooperation agreement was reached with PharmaCept, a German company, and the exclusive market rights for the EmboCept® series of products were obtained. 

From April 14 to April 17, 2019, the annual grand ceremony and the 13th anniversary of Winhealth Pharma Group was held in Dragon Hotel Hangzhou, officially marking the Winhealth 2.0 Era, and starting the industry's first CDCO model! 

2018  Round B financing was completed, and the funds available totaled to about 520 million yuan

Dec. 2018  A strategic cooperation agreement was signed with Italy's Bruschettini S.R.L, and the exclusive agency right for the product Taurolite® in China was obtained.

November 2018  The 'Signing ceremony for Contractubex®50g & Lornithine Laspartate and strategic cooperation seminar' was held with Merz Pharma GmbH (Germany).

October 20, 2018  The '20th Anniversary of marketing of Mucosolvan' was held with Boehringer Ingelheim.

July 25, 2018  The 'Overwhelming     Celebration on sales of one million boxes of Coniel®' was held with Kyowa Hakko Kirin China Pharmaceutical Co., Ltd. in the headquarters in Hangzhou. 

May 31, 2018  Winhealth Health Industrial Park won the title of 'Best Operator Platform' in Xiacheng District, Hangzhou. 

The 2018 China Healthcare investment & Partnering Symposium(CHIPS) and Hangzhou CBD Investment Forum, which was co-hosted by Winhealth Pharma Group, was successfully concluded at InterContinental Hotel in Hangzhou. 

A strategic cooperation agreement was signed with Xi'an-Janssen, and the exclusive promotion right of the product Sporanox® in China was obtained. 

A strategic cooperation agreement was signed with AsahiKASEI, and the exclusive agency right of the product Eril® in China was obtained. 

A strategic cooperation agreement was signed with Novartis, and the exclusive agency right for the product Hycamtin® in China was obtained. 

A strategic cooperation agreement was signed with Beaufour Ipsen, and the exclusive promotion right of the product Tanakan® in China was obtained. 

November 2017  A strategic cooperation agreement was signed with Boehringer Ingelheim, and the exclusive promotion right of the product Mucosolvan® in China was obtained. 

October 2017  A strategic cooperation agreement was signed with Merz Pharma GmbH (Germany) , and the exclusive agency right of Contractubex® in China was obtained.

May 2017  A strategic cooperation agreement was signed with Kyowa Hakko Kirin China Pharmaceutical Co., Ltd., and the exclusive promotion right of the product Coniel®in China was obtained.

December 2015  A strategic cooperation agreement was signed with Roche, and the exclusive promotion right of the product Oseltamivir® in China was obtained.

April 2015  A strategic cooperation agreement was signed with Pfizer, and the exclusive agency right of the product Unasyn® in China was obtained.

2013  The exclusive agency right of 'Sabal Soft Capsule' in China was obtained.

2011  The wholly-owned acquisition of 'Zhejiang Medical Technology Development Co., Ltd.' was completed.

2007-2010  We established cooperation with Qilu Pharmaceutical, LUYE Pharmaceutical, AOSAIKANG Pharmaceutical and other pharmaceutical companies, and obtained the agency right of a number of varieties in Zhejiang.

April 2006  Hangzhou Weining Medical Technology Co., Ltd., which was the predecessor of Winhealth Pharma Group, was established in Hangzhou